Fundz

NGM Bio Appoints Dr. Wendy Yeh as Chief Medical Officer, Dr. Hsiao D. Lieu Steps Down

PRIVATEFeb 04, 2025

Position

Chief Medical Officer

Company

NGM Bio

Wendy Yeh
wyeh@ngmbio.com
San FranciscoBiotechnologyHealth CareTherapeutics

Description

NGM Biopharmaceuticals, Inc. (NGM Bio) has announced the appointment of Dr. Wendy Yeh as Chief Medical Officer

Quick answer

NGM Bio Appoints Dr. Wendy Yeh as Chief Medical Officer, Dr. Hsiao D. Lieu Steps Down (February 4, 2025). NGM Bio is based in San Francisco, California, United States.

What did NGM Bio announce on February 4, 2025?
NGM Biopharmaceuticals, Inc. (NGM Bio) has announced the appointment of Dr. Wendy Yeh as Chief Medical Officer
What does NGM Bio do?
NGM Bio is a biotech company focused on developing innovative therapies for serious, rare conditions with significant unmet patient needs.
Where is NGM Bio based?
NGM Bio is based in San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
Uvax Bio (February 4, 2025), Commit Biologics (February 2, 2025), Daiichi Sankyo (January 31, 2025) and Santhera Pharmaceuticals (February 10, 2025) also announced leadership changes within 45 days of NGM Bio.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at NGM Bio, and when

A new leader at NGM Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day NGM Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NGM Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NGM Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NGM Bio

Location

San Francisco, California, United States

About

NGM Bio is a biotech company focused on developing innovative therapies for serious, rare conditions with significant unmet patient needs. The company aims to address underlying biological mechanisms of diseases such as primary sclerosing cholangitis (PSC) and hyperemesis gravidarum (HG) to provide potential treatment options. NGM Bio is committed to advancing clinical development efforts to benefit patients with rare conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NGM Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

David
Likely contact at this company
••••••••@••••••••

See David's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for NGM Bio's next move

Learn about Strategic plan

NGM Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.